| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $32.3M | +66.1% |
| R&D Expense | $1.2M | +200.0% |
| SG&A Expense | $262.6M | +495.8% |
| Operating Income | -$268.2M | -423.1% |
| Pre-tax Income | -$276.6M | -292.0% |
| Income Tax | $39K | +333.3% |
| Net Income | -$276.6M | -292.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $262.3M | — |
| Accounts Receivable | $12.6M | +104.7% |
| Inventory | $2.7M | -55.7% |
| Current Assets | $298.6M | — |
| Total Assets | $473.9M | +36.8% |
| Current Liabilities | $96.1M | — |
| Long-term Debt | $40.8M | +0.3% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$93.3M | -62.8% |
| Capital Expenditures | $56.5M | +234.1% |
| Investing Cash Flow | -$57.3M | -244.2% |
| Financing Cash Flow | $353.8M | +190.1% |
| Free Cash Flow | -$149.7M | -101.9% |
| Total Liabilities |
| $191.8M |
| +1451.3% |
| Stockholders' Equity | $282.1M | +5542.7% |